D-0236-2017 Class II Terminated

Recalled by Sandoz Incorporated — Broomfield, CO

FDA drug recall D-0236-2017 was initiated by Sandoz Incorporated on Dec 22, 2016 and is designated Class II. Reason for recall: Failed dissolution specification: recalled due to an out of specification dissolution result of 40% (Specification: NLT 80%) The recall status is terminated (terminated Sep 18, 2017). Affected quantity: 96 bottles.

Recall details

Product Type
Drugs
Report Date
Jan 4, 2017
Initiation Date
Dec 22, 2016
Termination Date
Sep 18, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
96 bottles

Product description

Nadolol Tablets, USP, 40mg, packaged in 1000-count bottle, Rx Only, Manufactured by Sandoz Inc., Princeton, NJ 08540, NDC 0781-1182-10

Reason for recall

Failed dissolution specification: recalled due to an out of specification dissolution result of 40% (Specification: NLT 80%)

Distribution pattern

MS and OH.

Code information

Lot GG1539

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0236-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0236-2017. Report a data issue: hello@regdatalab.com.